S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(0.43%) $10.74
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realtime updates for Sana Biotechnology, Inc. [SANA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
44.44%
return 16.75%
SELL
44.44%
return -3.46%
Last Updated17 May 2024 @ 16:00

2.11% $ 8.73

BUY 134305 min ago

@ $7.22

Issued: 14 Feb 2024 @ 15:45


Return: 21.00%


Previous signal: Feb 13 - 14:34


Previous signal: Sell


Return: 12.56 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):
Profile picture for Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Stats
Today's Volume 1.26M
Average Volume 1.92M
Market Cap 1.93B
EPS $0 ( 2024-05-13 )
Next earnings date ( $-0.270 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -5.74
ATR14 $0.0160 (0.18%)
Insider Trading
Date Person Action Amount type
2024-04-05 Bishop Hans Edgar Buy 2 774 Common Stock
2024-04-01 Fmr Llc Buy 0 Common Stock
2024-03-08 Yang Patrick Y Sell 25 000 Common Stock
2024-03-07 Williams Douglas E Buy 301 875 Stock Option (Right to Buy)
2024-03-07 Williams Douglas E Buy 67 083 Restricted Stock Units
INSIDER POWER
6.38
Last 97 transactions
Buy: 15 455 910 | Sell: 11 982 863

Volume Correlation

Long: 0.30 (neutral)
Short: -0.56 (weak negative)
Signal:(56.177) Neutral

Sana Biotechnology, Inc. Correlation

10 Most Positive Correlations
ECHO0.929
KRTX0.928
BRIVU0.918
KNSL0.914
MRUS0.912
MSDA0.911
LIBY0.911
KBAL0.911
TA0.911
MSDAU0.909
10 Most Negative Correlations
SRNGW-0.943
SRNG-0.935
CYXT-0.929
OMCL-0.919
LSAQ-0.915
BIOL-0.914
SGLB-0.912
CAR-0.909
QLYS-0.909
CYAN-0.908

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sana Biotechnology, Inc. Correlation - Currency/Commodity

The country flag -0.54
( weak negative )
The country flag -0.17
( neutral )
The country flag 0.00
( neutral )
The country flag -0.66
( moderate negative )
The country flag 0.54
( weak )
The country flag -0.76
( moderate negative )

Sana Biotechnology, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $-30.87M (0.00 %)
EPS: $-1.460
FY 2023
Revenue: $0
Gross Profit: $-30.87M (0.00 %)
EPS: $-1.460
FY 2022
Revenue: $0
Gross Profit: $-27.73M (0.00 %)
EPS: $-1.410
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.958

Financial Reports:

No articles found.

Sana Biotechnology, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators